Kiadis Pharma NV services

Transformative antibodies from our platform. Our discovery platform enables us to develop fully human therapeutic antibodies for the treatment of immune-related diseases. Therapies using monoclonal antibodies have proven to be effective in several inflammatory and immune diseases. A common approach is to use antibodies to target cytokines, receptors, and other signalling molecules. We are determined to exploit the strength of our antibody discovery platform to deliver a new generation of therapeutic antibodies that tackle immune disorders, which continue to represent a high level of unmet clinical need.

Innovative antibody-based molecular concepts. New treatments for cancer that leverage our own immune system to attack and destroy cancer cells can provide long-term and durable therapeutic responses in patients suffering from life-threatening malignancies. These benefits for patients have been driven by recently developed therapeutic antibodies binding with high specificity to drug targets on immune and cancer cells.

Our infectious disease work, in partnership with the Bill & Melinda Gates Foundation has built strong capabilities where we are developing product candidates that target pathogens that are predominant in the developing world.

Our efforts in haematology are currently focussed on non-malignant blood disorders including forms of anaemia. Our approach is to identify functional and developable lead molecules and quickly proceed to verified animal disease models to study the direct impact of our drug candidates with clinically relevant read outs. We build our know-how by working on common pathways that are frequently used in this area, often with varying tissue specificity or multiple functionality depending on the disease and the tissue distribution. Our antibody-based drug molecules can provide exquisite specificity for those targets even in situations where the sequence homology between mouse and human is high and where multiple related ligands exist that promote different biological effects.